HomeCompareBIOGY vs BTI

BIOGY vs BTI: Dividend Comparison 2026

BIOGY yields 6.44% · BTI yields 5.38%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BIOGY wins by $26810.94M in total portfolio value
10 years
BIOGY
BIOGY
● Live price
6.44%
Share price
$11.00
Annual div
$0.71
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26810.97M
Annual income
$26,033,859,346.54
Full BIOGY calculator →
BTI
BTI
● Live price
5.38%
Share price
$58.47
Annual div
$3.15
5Y div CAGR
11.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.7K
Annual income
$2,786.64
Full BTI calculator →

Portfolio growth — BIOGY vs BTI

📍 BIOGY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBIOGYBTI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BIOGY + BTI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BIOGY pays
BTI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BIOGY
Annual income on $10K today (after 15% tax)
$547.03/yr
After 10yr DRIP, annual income (after tax)
$22,128,780,444.56/yr
BTI
Annual income on $10K today (after 15% tax)
$457.40/yr
After 10yr DRIP, annual income (after tax)
$2,368.64/yr
At 15% tax rate, BIOGY beats the other by $22,128,778,075.92/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BIOGY + BTI for your $10,000?

BIOGY: 50%BTI: 50%
100% BTI50/50100% BIOGY
Portfolio after 10yr
$13405.51M
Annual income
$13,016,931,066.59/yr
Blended yield
97.10%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

BIOGY
No analyst data
Altman Z
24.5
Piotroski
5/9
BTI
Analyst Ratings
12
Buy
4
Hold
2
Sell
Consensus: Buy
Price Target
$40.00
-31.6% upside vs current
Range: $40.00 — $40.00
Altman Z
2.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BIOGY buys
0
BTI buys
0
No recent congressional trades found for BIOGY or BTI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBIOGYBTI
Forward yield6.44%5.38%
Annual dividend / share$0.71$3.15
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%11.3%
Portfolio after 10y$26810.97M$37.7K
Annual income after 10y$26,033,859,346.54$2,786.64
Total dividends collected$26757.34M$14.3K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: BIOGY vs BTI ($10,000, DRIP)

YearBIOGY PortfolioBIOGY Income/yrBTI PortfolioBTI Income/yrGap
1← crossover$11,987$1,287.13$11,299$598.92+$688.00BIOGY
2$15,710$2,883.92$12,794$703.91+$2.9KBIOGY
3$23,875$7,064.71$14,518$829.07+$9.4KBIOGY
4$45,613$20,067.60$16,513$978.64+$29.1KBIOGY
5$120,470$71,663.60$18,827$1,157.84+$101.6KBIOGY
6$482,681$353,778.32$21,518$1,373.12+$461.2KBIOGY
7$3,165,940$2,649,470.74$24,657$1,632.46+$3.14MBIOGY
8$35,869,920$32,482,364.61$28,329$1,945.74+$35.84MBIOGY
9$726,275,008$687,894,193.55$32,637$2,325.33+$726.24MBIOGY
10$26,810,973,605$26,033,859,346.54$37,708$2,786.64+$26810.94MBIOGY

BIOGY vs BTI: Complete Analysis 2026

BIOGYStock

BioGaia AB (publ) develops, markets, and sells probiotic products with documented health benefits worldwide. It operates through three segments: Pediatrics, Adult Health, and Other. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee's dairy product. The Other segment provides packaging solutions. The company offers its products in the areas of infantile colic and digestive health in children; antibiotic-associated and acute diarrhoea; gingivitis; periodontal disease; general health; Helicobacter pylori–the gastric ulcer bacterium; and low bone density. It offers its products under the BioGaia brand name. BioGaia AB (publ) was founded in 1990 and is headquartered in Stockholm, Sweden.

Full BIOGY Calculator →

BTIConsumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →
📬

Get this BIOGY vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BIOGY vs SCHDBIOGY vs JEPIBIOGY vs OBIOGY vs KOBIOGY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.